XML 63 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2013
Fair Value Disclosures [Abstract]  
Fair Value Hierarchy Tables Present Information about Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2013:
(Dollars in thousands)
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Balance at March 31, 2013
Assets
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
U.S. treasury securities
 
$

 
$
100,046

 
$

 
$
100,046

U.S. agency debentures
 

 
3,483,903

 

 
3,483,903

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 

 
1,347,830

 

 
1,347,830

Agency-issued collateralized mortgage obligations - fixed rate
 

 
3,855,067

 

 
3,855,067

Agency-issued collateralized mortgage obligations - variable rate
 

 
1,602,853

 

 
1,602,853

Agency-issued commercial mortgage-backed securities
 

 
419,335

 

 
419,335

Municipal bonds and notes
 

 
90,503

 

 
90,503

Equity securities
 
5,879

 
2,747

 

 
8,626

Total available-for-sale securities
 
5,879

 
10,902,284

 

 
10,908,163

Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 

 

 
701,076

 
701,076

Other venture capital investments
 

 

 
124,786

 
124,786

Total non-marketable securities (fair value accounting)
 

 

 
825,862

 
825,862

Other assets:
 
 
 
 
 
 
 
 
Marketable securities
 
913

 
9,265

 

 
10,178

Interest rate swaps
 

 
8,506

 

 
8,506

Foreign exchange forward and option contracts
 

 
13,752

 

 
13,752

Equity warrant assets
 

 
6,287

 
66,046

 
72,333

Loan conversion options
 

 
1,529

 

 
1,529

Client interest rate derivatives
 

 
653

 

 
653

Total assets (1)
 
$
6,792

 
$
10,942,276

 
$
891,908

 
$
11,840,976

Liabilities
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 
$

 
$
11,513

 
$

 
$
11,513

Client interest rate derivatives
 

 
691

 

 
691

Total liabilities
 
$

 
$
12,204

 
$

 
$
12,204

 
 
(1)
Included in Level 1, Level 2, and Level 3 assets are $0.8 million, $8.8 million, and $740 million, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2012:
(Dollars in thousands)
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Balance at December 31, 2012
Assets
 
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
 
U.S. treasury securities
 
$

 
$
25,247

 
$

 
$
25,247

U.S. agency debentures
 

 
3,447,628

 

 
3,447,628

Residential mortgage-backed securities:
 
 
 
 
 
 
 
 
Agency-issued mortgage-backed securities
 

 
1,473,433

 

 
1,473,433

Agency-issued collateralized mortgage obligations - fixed rate
 

 
4,103,974

 

 
4,103,974

Agency-issued collateralized mortgage obligations - variable rate
 

 
1,772,748

 

 
1,772,748

Agency-issued commercial mortgage-backed securities
 

 
422,098

 

 
422,098

Municipal bonds and notes
 

 
93,529

 

 
93,529

Equity securities
 
4,520

 

 

 
4,520

Total available-for-sale securities
 
4,520

 
11,338,657

 

 
11,343,177

Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 

 

 
665,921

 
665,921

Other venture capital investments
 

 

 
127,091

 
127,091

Total non-marketable securities (fair value accounting)
 

 

 
793,012

 
793,012

Other assets:
 
 
 
 
 
 
 
 
Marketable securities
 
1,144

 
9,184

 

 
10,328

Interest rate swaps
 

 
9,005

 

 
9,005

Foreign exchange forward and option contracts
 

 
13,541

 

 
13,541

Equity warrant assets
 

 
8,143

 
66,129

 
74,272

Loan conversion options
 

 
890

 

 
890

Client interest rate derivatives
 

 
558

 

 
558

Total assets (1)
 
$
5,664

 
$
11,379,978

 
$
859,141

 
$
12,244,783

Liabilities
 
 
 
 
 
 
 
 
Foreign exchange forward and option contracts
 
$

 
$
12,847

 
$

 
$
12,847

Client interest rate derivatives
 

 
590

 

 
590

Total liabilities
 
$

 
$
13,437

 
$

 
$
13,437

 
 
(1)
Included in Level 1, Level 2, and Level 3 assets are $1.1 million, $8.7 million, and $708 million, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.

Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis
The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for the three months ended March 31, 2013 and 2012, respectively:
(Dollars in thousands)
 
Beginning
Balance
 
Total Realized and Unrealized Gains (Losses) Included in Income
 
Purchases  
 
Sales
 
Issuances  
 
Distributions and Other Settlements
 
Transfers Into Level 3 
 
Transfers Out of Level 3
 
Ending
Balance
Three months ended March 31, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
665,921

 
$
22,510

 
$
29,744

 
$

 
$

 
$
(17,099
)
 
$

 
$

 
$
701,076

Other venture capital investments
 
127,091

 
2,188

 
166

 
(21
)
 

 
(1,077
)
 

 
(3,561
)
 
124,786

Total non-marketable securities (fair value accounting) (1)
 
793,012

 
24,698

 
29,910

 
(21
)
 

 
(18,176
)
 

 
(3,561
)
 
825,862

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
66,129

 
1,459

 

 
(2,250
)
 
1,926

 
364

 

 
(1,582
)
 
66,046

Total assets
 
$
859,141

 
$
26,157

 
$
29,910

 
$
(2,271
)
 
$
1,926

 
$
(17,812
)
 
$

 
$
(5,143
)
 
$
891,908

Three months ended March 31, 2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Venture capital and private equity fund investments
 
$
611,824

 
$
12,104

 
$
21,716

 
$

 
$

 
$
(25,288
)
 
$

 
$

 
$
620,356

Other venture capital investments
 
124,121

 
(3,587
)
 
7,724

 
(307
)
 

 

 

 

 
127,951

Other investments
 
987

 
21

 

 

 

 
(6
)
 

 

 
1,002

Total non-marketable securities (fair value accounting) (1)
 
736,932

 
8,538

 
29,440

 
(307
)
 

 
(25,294
)
 

 

 
749,309

Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity warrant assets (2)
 
63,030

 
3,795

 

 
(3,643
)
 
2,300

 
1

 

 
(266
)
 
65,217

Total assets
 
$
799,962

 
$
12,333

 
$
29,440

 
$
(3,950
)
 
$
2,300

 
$
(25,293
)
 
$

 
$
(266
)
 
$
814,526

 
 
(1)
Realized and unrealized gains (losses) are recorded on the line items “gains on investment securities, net”, and “other noninterest income”, components of noninterest income.
(2)
Realized and unrealized gains (losses) are recorded on the line item “gains on derivative instruments, net”, a component of noninterest income.
Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held
The following table presents the amount of unrealized gains (losses) included in earnings during the period (which is inclusive of noncontrolling interest) attributable to Level 3 assets still held at March 31, 2013 and March 31, 2012:
 
 
Three months ended March 31,
(Dollars in thousands)
 
2013
 
2012
Non-marketable securities (fair value accounting):
 
 
 
 
Venture capital and private equity fund investments
 
$
22,621

 
$
11,649

Other venture capital investments
 
526

 
(2,610
)
Other investments
 

 
21

Total non-marketable securities (fair value accounting) (1)
 
23,147

 
9,060

Other assets:
 
 
 
 
Equity warrant assets (2)
 
1,181

 
1,674

Total unrealized gains
 
$
24,328

 
$
10,734

Unrealized gains attributable to noncontrolling interests
 
$
21,187

 
$
7,242

 

(1)
Unrealized gains (losses) are recorded on the line items “gains on investment securities, net”, and “other noninterest income”, components of noninterest income.
(2)
Unrealized gains (losses) are recorded on the line item “gains on derivative instruments, net”, a component of noninterest income.
Quantitative Information About Significant Unobservable Inputs
The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at March 31, 2013 and December 31, 2012. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value.
(Dollars in thousands)
 
Fair value
 
Valuation Technique
 
Significant Unobservable Inputs
 
Weighted 
Average
March 31, 2013:
 
 
 
 
 
 
 
 
Other venture capital investments (fair value accounting)
 
$
124,786

 
Private company equity pricing
 
(1)
 
(1
)
Equity warrant assets (private portfolio)
 
66,046

 
Modifed Black-Scholes option pricing model
 
Volatility
 
42.0
%
 
 
 
 
 
Risk-Free interest rate
 
0.4
%
 
 
 
 
 
Marketability discount (2)
 
22.5
%
 
 
 
 
 
Remaining life assumption (3)
 
45.0
%
December 31, 2012:
 
 
 
 
 
 
 
 
Other venture capital investments (fair value accounting)
 
127,091

 
Private company equity pricing
 
(1)
 
(1
)
Equity warrant assets (private portfolio)
 
66,129

 
Modifed Black-Scholes option pricing model
 
Volatility
 
45.2
%
 
 
 
 
 
Risk-Free interest rate
 
0.4
%
 
 
 
 
 
Marketability discount (2)
 
22.5
%
 
 
 
 
 
Remaining life assumption (3)
 
45.0
%
 
 
 
(1)
In determining the fair value of our other venture capital investment portfolio, we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Additionally, we have ongoing communication with the portfolio companies and venture capital fund managers, to determine whether there is a material change in fair value. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.
(2)
Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based on long-run averages and is influenced over time by various factors, including market conditions. On a quarterly basis, a sensitivity analysis is performed on our marketability discount.
(3)
We adjust the contractual remaining term of private company warrants based on our best estimate of the actual remaining life, which we determine by utilizing historical data on cancellations and exercises. At March 31, 2013, the weighted average contractual remaining term was 6.4 years, compared to our estimated remaining life of 2.9 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption.
Summary of Estimated Fair Values of Financial Instruments Not Carried at Fair Value
The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at March 31, 2013 and December 31, 2012:
 
 
 
 
Estimated Fair Value
(Dollars in thousands)
 
Carrying Amount
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
March 31, 2013:
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
1,519,249

 
$
1,519,249

 
$

 
$

Non-marketable securities (cost and equity method accounting)
 
389,926

 

 

 
431,115

Net commercial loans
 
7,915,726

 

 

 
8,086,157

Net consumer loans
 
816,959

 

 

 
853,520

FHLB and FRB stock
 
39,806

 

 

 
39,806

Accrued interest receivable
 
64,375

 

 
64,375

 

Financial liabilities:
 
 
 
 
 
 
 
 
Other short-term borrowings
 
7,460

 
7,460

 

 

Non-maturity deposits (1)
 
19,137,749

 
19,137,749

 

 

Time deposits
 
172,159

 

 
172,054

 

5.375% Senior Notes
 
348,048

 

 
390,831

 

6.05% Subordinated Notes (2)
 
53,993

 

 
58,390

 

7.0% Junior Subordinated Debentures
 
55,153

 

 
53,608

 

Accrued interest payable
 
1,967

 

 
1,967

 

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
Commitments to extend credit
 

 

 

 
21,109

December 31, 2012:
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
1,008,983

 
$
1,008,983

 
$

 
$

Non-marketable securities (cost and equity method accounting)
 
391,253

 

 

 
425,741

Net commercial loans
 
8,013,563

 

 

 
8,180,597

Net consumer loans
 
822,719

 

 

 
860,772

FHLB and FRB stock
 
39,806

 

 

 
39,806

Accrued interest receivable
 
64,167

 

 
64,167

 

Financial liabilities:
 
 
 
 
 
 
 
 
Federal funds purchased
 
160,000

 
160,000

 

 

Other short-term borrowings
 
6,110

 
6,110

 

 

Non-maturity deposits (1)
 
19,021,264

 
19,021,264

 

 

Time deposits
 
155,188

 

 
155,027

 

5.375% Senior Notes
 
347,995

 

 
393,701

 

6.05% Subordinated Notes (2)
 
54,571

 

 
61,639

 

7.0% Junior Subordinated Debentures
 
55,196

 

 
51,959

 

Accrued interest payable
 
6,494

 

 
6,494

 

Off-balance sheet financial assets:
 
 
 
 
 
 
 
 
Commitments to extend credit
 

 

 

 
20,562

 
 
(1)
Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.
(2)
At March 31, 2013 and December 31, 2012, included in the carrying value and estimated fair value of our 6.05% Subordinated Notes was $8.5 million and $9.0 million, respectively, related to hedge accounting associated with the notes.
Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments
The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of March 31, 2013:
(Dollars in thousands)
 
Carrying Amount      
 
Fair Value        
 
Unfunded
Commitments      
Non-marketable securities (fair value accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments (1)
 
$
701,076

 
$
701,076

 
$
448,482

Non-marketable securities (equity method accounting):
 
 
 
 
 
 
Other investments (2)
 
52,180

 
53,679

 
17,258

Non-marketable securities (cost method accounting):
 
 
 
 
 
 
Venture capital and private equity fund investments (3)
 
160,870

 
199,504

 
51,007

Total
 
$
914,126

 
$
954,259

 
$
516,747

 
 
(1)
Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds. These investments represent investments in venture capital and private equity funds that invest primarily in U.S. and global technology and life sciences companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $624 million and $440 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.
(2)
Other investments within non-marketable securities (equity method accounting) include investments in debt funds and venture capital and private equity fund investments that invest in or lend money to primarily U.S. and global technology and life sciences companies. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds.
(3)
Venture capital and private equity fund investments within non-marketable securities (cost method accounting) include investments in venture capital and private equity fund investments that invest primarily in U.S. and global technology and life sciences companies. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of the terms of the funds.